Effective 1 February 2015, the Mergers & Acquisitions business within Transaction Advisory Services will be expanded, with Ronald Sauser becoming the new Leader.
The abandonment of the Swiss franc's cap took many companies by surprise. EY recommends that affected companies rapidly put together an interdisciplinary task force.
Mergers and acquisitions by large life science companies reached record volume of USD 223 billion in 2014. Biotech and specialty pharma companies were particularly active.
The positive outlook for the Swiss real estate investment market continues. Prices for residential properties in prime locations are expected to climb.
